ArticleOphthalmology and therapy2026

Prospective Real-World Outcomes After Switching to Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration with High Treatment Burden.

Christoph Spartalis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.